Unilife Corporation (UNS)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Unilife Corporation
Stock Code: UNS
Website: www.unilife.com.au
GICS Sub-Industry: Health Care Equipment
Market Cap ($M): 191
Equiv. Shares (M): 273

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.700 $ 0.710 $ 0.720 $ 0.700 $ 0.745 1,344,393 $ -0.045  -6.040 %

Company Overview

Business Description:
Unilife Corporation Limited (UNS) is a U.S. based developer and supplier of injectable drug delivery systems. Its proprietary technologies include prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Its customers include pharmaceutical manufacturers and suppliers of medical equipment. UNS’s products are distributed in both Australia and overseas.

Strategy Analysis:
UNS is focussed on the development, production and sale of safety syringes, the expansion of their global operational and commercial presence and, the establishment of long term supply relationships with multinational pharmaceutical and healthcare equipment companies. Unilife Corporation reported a net loss of US$27.14m for the half-year ended 31 December 2012. Revenues from ordinary activities were US$1.4m, down 54.3% from the same period last year. Basic and Diluted EPS were (0.35) US cents compared to (0.35) US cents last year. The net operating cash outflow was US$20.74m compared to an outflow of US$18.76m in the pcp. No dividend was declared.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -61.5 -10.5 -- 0.0 0.0 0.0 --
2013  A -68.1 -14.0 -- 0.0 0.0 0.0 --
2012  A -51.3 -12.7 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Cochlear (COH) $4,043 M -0.2934 0.5815 0.1668 43.1547 27.2864 23.3854 3.58 2.67 3.04
Greencross (GXL) $1,028 M 2.8120 0.1526 0.2354 28.5891 24.8050 20.0784 1.36 1.63 2.43
ResMed (RMD) $7,450 M 0.1393 0.0975 0.1499 20.5495 18.7236 16.2833 2.06 2.28 2.41
Unilife (UNS) $203 M -- -- -- -- -- -- 0.00 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
UNS -- -- 66.7 -- 26.4
Market 0.88 15.0 1.23 1.69 1.48
Sector 0.62 20.9 2.37 1.45 2.31

Name Position Start Date
Mr Alan Denis Shortall Chief Executive Officer 02 July 2009
Mr Slavko (Jim) James Joseph Bosnjak Non-Executive Chairman 05 November 2009
Mr Jeffrey Noel Carter Non-Executive Director 05 November 2009
Mr William Galle Non-Executive Director 05 November 2009
Mr John M Lund Non-Executive Director 05 November 2009
Ms Mary Katherine (Kate) Wold Non-Executive Director 11 May 2010

Name Position
R. Richard Wieland II Chief Financial Officer and Executive Vice President
Ramin Mojdeh Chief Operating Officer and Executive Vice President
John Ryan Company Secretary,Senior Vice President and General Counsel
Mark V. Iampietro Vice President of Quality and Regulatory Affairs
J. Christopher Naftzger Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer

Substantial Shareholders
Holding Name
-- (--%) Not Disclosed in Annual Report

Calendar of Events
Date Event
15 September 2015 Report (Annual)
28 August 2015 Report (Prelim)
10 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Active Investing and Trading

An educational booklet with information on how analysis and risk management can enhance your share investments.

More details...


The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?

Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.

Bega Cheese holds back in three-way bidding war for WCB

The Age 19/12/2013 | Bega Cheese began the battle for Warrnambool Cheese & Butter but three months on it appears to be the first casualty of the bidding war.


Sponsored Links